author-photo

Ron A. H. J. Gilissen

Johnson & Johnson Pharmaceutical Research and Development

12

Papers

287

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Prediction of Human Oral Plasma Concentration-Time Profiles Using Preclinical Data

2011 Clinical Pharmacokinectics
Show All
- Source
- Cite
- Save
Citations (21)
Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay

2009 Journal of Computer-aided Molecular Design
Show All
- Source
- Cite
- Save
Citations (6)
Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.

2008 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (22)
Predicting oral clearance in humans: how close can we get with allometry?

2008 Clinical Pharmacokinectics
Show All
- Source
- Cite
- Save
Citations (42)
Discovery of Potent, Orally Bioavailable Small-Molecule Inhibitors of the Human CCR2 Receptor

2008 ChemMedChem
Show All
- Source
- Cite
- Save
Citations (13)
A single hERG mutation underlying a spectrum of acquired and congenital long QT syndrome phenotypes.

2007 Journal of Molecular and Cellular Cardiology
Show All
- Source
- Cite
- Save
Citations (16)
The use of liquid chromatography-atmospheric pressure chemical ionization mass spectrometry to explore the in vitro metabolism of cyanoalkyl piperidine derivatives.

2005 Biomedical Chromatography
Show All
- Source
- Cite
- Save
Citations (5)
Simultaneous measurement of drug metabolic stability and identification of metabolites using ion‐trap mass spectrometry

2003 Rapid Communications in Mass Spectrometry
Show All
- Source
- Cite
- Save
Citations (52)